To further investigate the effect of Chlamydia infection on the lung microbiota, we performed a comparative analysis of the microbial communities of 40 BALF samples from different Chlamydia infection subgroups (CP and PA groups) and clinical control groups (O and N groups). The gene discussed is CP; the disease is chlamydia infectious disease.